Guest Editors
Giovanni Tossetta, Department of experimental and clinical medicine, Faculty of Medicine and Surgery, Università Politecnica delle Marche, Ancona, Italy. E-mail: g.tossetta@pm.univpm.it
Sonia Fantone, Department of experimental and clinical medicine, Università Politecnica delle Marche, Ancona, Italy. E-mail: s.fantone@inrca.it
Summary
The occurrence of urological cancers has significantly increased over the past 50 years but, despite advances in medical tumor therapy, the occurrence of chemotherapy resistance and metastatic disease is still a common cause of death in patients affected by these types of malignancies. For these reasons, it is necessary to develop and study new therapeutic approaches that can improve the diagnosis and treatment of urogenital cancer in order to improve the outcome of these malignancies. To this aim, we need a better understanding of the molecular mechanisms occurring in urological malignancies in order to develop new and efficient molecular biomarkers able to predict tumor behavior and risk of disease recurrence and chemoresistance.
This Special Issue of Oncology Research, therefore, welcomes original research articles and reviews related to the molecular mechanisms of urogenital cancers.
Keywords
Prostate cancer; Bladder cancer; Renal cell carcinoma; Testicular cancer; Cancer biomarker; Diagnosis; Therapy; Treatments
Login
Register
Submit a Paper
Propose a Special lssue